Novavax (United States)

Novavax (United States)

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Novavax (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

80%


Total
Publications

265


Total Open
Publications

213


Total
Citations

12K


Open Access
Percentage

80%


Total
Publications

265


Total Open
Publications

213


Total
Citations

12K

Wikipedia

Website

download

Breakdown

16% 42% 23% 19%

Publisher Open

16%

Both

42%

Other Platform Open

23%

Closed

19%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

40%OA Journal

OA Journal 40%

61

Hybrid 45%

69

No Guarantees 15%

23

Other Platform Open

Domain 74%

127

Other Internet 26%

44

Preprint 22%

38

Institution 20%

35

Public 9%

15

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
131
Europe PMC
Domain
53
DOI
Other Internet
39
medRxiv
Preprint
23
Semantic Scholar
Public
12
Research Square
Preprint
8
bioRxiv
Preprint
7
St George's University of London - St George's Online Research Archive
Institution
6
University of Oxford - Oxford University Research Archive (ORA)
Institution
4
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
4
1 / 5

Data updated 8 December 2024